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Introduction
All the living organisms constantly communicate with the environment. Both unicellular organisms and cells within a multicellular organism must be ready to adapt to several perturbations occurring in the external world (Turner 2009 ). The capacity to rapidly sense, integrate signals and elaborate a response is a signature of the plasticity and the robustness of a biological system (Kitano 2007) . All the external stimuli and the environmental changes influence the cell behavior through the activation of specific cellular programs, resulting in rapid and stable alterations in gene expression.
The epigenetic machinery plays an important role in the establishment of peculiar patterns of gene expression and hence in the regulation of physiological responses. Epigenetics include all the mechanisms that heritably change the transcriptome by modifying chromatin structure without variations in the DNA sequence ( figure 1A ). These mechanisms make DNA locally more packaged or accessible to transcriptional factors and RNA polymerases (i.e. eu-/heterochromatin M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT respectively). For this reason, chromatin is much more than a neutral system for packaging and condensing genomic DNA, but it is a highly dynamic platform that can be modified at different levels. The combination of different chromatin modifications constitutes the epigenetic code.
DNA methylation
The first layer of the epigenetic landscape architecture is DNA methylation: this covalent modification occurs at cytosine residues located at 5' of guanine residues ("CpG islands") and is mediated by DNA methyltransferase enzymes (Dnmt). In general, an exclusivity between active and "open" chromatin structures and DNA methylation exists (Weber et al. 2007 ). In fact, in mammalian genomes, the CG rich regions are prevalently unmethylated, for example high CpGcontent promoters (HCPs) activate the expression of genes essential for cellular functions and are active by default (i.e. housekeeping genes promoters). On the contrary, the CG poor chromatin, such as low CpG-content promoters (LCPs), is methylated and seems to be selectively activated, for example by specific transcription factors.
Histone modifications
The second layer of the epigenome architecture is the "histone code", a combination of a variety of M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
The diverse combination of different histone modifications in the same locus can provide a particular output in term of modulation of gene expression. Among the most important histone marks associated with an active transcription there are histone 3 lysine 4 tri-methylation (H3K4me3) at promoters, histone 3 lysine 4 mono and di-methylation (H3K4me1/me2) and histone 3 lysine 27 acetylation (H3K27ac) at enhancers, histone 3 lysine 36 tri-methylation (H3K36me3) and histone 3 lysine 79 tri-methylation (H3K79me3) along the gene bodies. On the contrary, among the most significant silenced chromatin marks there are histone 3 lysine 9 tri-methylation (H3K9me3), histone 3 lysine 27 di-and tri-methylation (H3K27me2/me3), histone 4 lysine 27 diand tri-methylation (H4K27me2/me3) and histone 4 lysine 20 tri-methylation (H4K20me3).
Non Coding RNAs (ncRNAs)
Other important epigenetic regulators are non-coding RNAs (ncRNAs) (figure 1B) (for detailed review see Sadakierska-chudy & Małgorzata 2015) . Among all, the class of long non-coding RNAs (lncRNAs > 200 nt in lenght) is the least characterized and their physiological role is still largely unknown. Recent investigations indicate that lncRNAs could play critical roles in essential physiological processes, such as nutrient sensing and maintenance of metabolic homeostasis. Most lncRNAs are localized in the nucleus and seem to be involved in the regulation of chromatin state.
In fact, they can guide chromatin-modifying complexes to specific genomic loci and it has been demonstrated that lncRNAs recruit chromatin-remodeling complexes to specific chromatin loci (Moran, Perera, and Khalil 2012) .
Another class of ncRNAs is the one of microRNAs (miRNAs). They are small single stranded RNA with 18-25 nucleotides in length that regulate mRNA degradation or protein translation. miRNAs can positively or negatively regulate expression of target genes (Ambros, 2001 , Lewis et al., 2003 , by inhibiting translation or by increasing degradation of target mRNA.
Epigenetic regulation mediated by miRNAs required the RNA-induced silencing complex (RISC), which is driven by miRNA on the target sequence via complementary base pairing. Interestingly it M A N U S C R I P T
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has been demonstrated that aberrant expression of miRs correlates with the onset of several metabolic diseases, including obesity, insulin resistance, type 2 diabetes mellitus, and fatty liver disease (Lynn 2009; Hulsmans, Keyzer, and Holvoet 2016) . Recently, many studies are combining these research areas to contribute to the advance of knowledge and, possibly, to identify new strategies of therapeutic intervention.
Nutrients influence epigenetic control of gene expression
It is now well known that epigenetic mechanisms not only regulate several important physiological processes such as embryonic development and aging, but they also play a central role in pathological processes such as cancer, inflammation, obesity, insulin resistance, type 2 diabetes mellitus, cardiovascular, neurodegenerative and immune diseases. It is likewise widely known that nutrients can modify pathophysiological processes by changing gene expression patterns through modifications of the epigenetic landscape resulting from alteration of metabolite levels (rev. in Lu & Thompson 2012; Katada et al. 2012; Keating & El-Osta 2015) . At this regard, nutrients can influence epigenome either by directly regulating enzymes that catalyze DNA methylation or histone modifications or by altering the levels of metabolic intermediates necessary for enzyme reactions (Choi and Friso 2010; Jang and Serra 2014) . In fact, all chromatin-modifying enzymes need coenzymes, such as ATP, Acetyl-CoA and S-adenosylmethionine (SAM) that function as phosphate, acetyl and methyl group donors. The level of these metabolites changes with the metabolism of energy-rich substrates such as carbohydrates and fatty acids present in diet (Martinez-Pastor, Cosentino, and Mostoslavsky 2013 ).
An important class of enzymes whose activity is directly dependent from the energetic status of the cell is the class III HDACs, also known as sirtuins (SIRT) (for details see review articles Ferrari et al. 2012; Ye et al. 2016) . Sirtuins are NAD + -dependent deacetylases, which cleave NAD + to create an ADP-ribose acceptor for the acetyl group, and hence their activity is sensitive to changes in the intracellular NAD + /NADH ratio. Mammalian sirtuins have been connected to a wide range of M A N U S C R I P T
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processes that encompass cellular stress resistance, genomic stability, tumorigenesis and they also play a central role in glucose and lipid metabolism (Finkel et al. 2009 ).
Moreover, it has been observed that compounds such as folic acid, vitamin B-12, methionine, choline and betaine can affect DNA and histone methylation through altering the levels of SAM and S-adenosylhomocysteine, an inhibitor of methyltransferases (Mentch et al. 2015) . Other water- Furthermore, bioactive components of food can modify epigenetic phenomena through directly affecting enzymes involved in epigenetic mechanisms. For instance, genistein and tea catechin influence DNA methyltransferases (Dnmt) activity. Resveratrol, butyrate, sulforaphane, and diallyl sulfide inhibit HDAC and curcumin inhibits HAT (Nian et al. 2010; Chiu et al. 2009 ).
Transgenerational epigenetic inheritance
It has been suggested that a memory of former metabolic states exists and that transient changes in nutrition may have a long-lasting impact on gene expression (Vickers 2014) , from previous generations and in particular from both mother and father (Woo and Patti 2008; Gluckman 2008; Ferguson-Smith and Patti 2011) . The relevant aspect of paternal transmission is that sperm transmits only genetic and epigenetic factors, modeled by paternal diet, and that these spermal epigenetic perturbations transmitted to offspring influence adult metabolic phenotype.
Given all these evidences, it is conceivable to envision that focused modulation of epigenetic mechanisms through diet or specific nutrients may prevent diseases and maintain healthy status.
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In this review, we will focus on the role of epigenetics in the regulation of lipid metabolism in rodent models and in humans, highlighting the importance of epigenetic remodeling in the pathophysiology of metabolic disorders.
Epigenetic regulation of lipid metabolism in rodents
2.1 DNA methylation
There are cumulating evidences that DNA methylation is susceptible to changes in environmental factors (Haan, Gevers, and Parker 1986; Henry et al. 1996; Staiger et al. 2006; Pogribny et al. 2006; Ghoshal et al. 2008) . For example, the presence of hypermethylated CpG sites has been demonstrated upstream to TSS (transcription start site) of Pparg gene, the master regulator of adipogenesis, in visceral white adipose tissue (WAT) in response to high fat diet in mice (Fujiki et al. 2009 ).
The genome wide study of Multhaup et al. showed 232 differentially methylated regions (DMRs) of the DNA correlated with diet in murine adipocytes (Multhaup et al. 2015) . This study highlighted hypermethylated regions near genes involved in lipid metabolic pathways, whereas hypomethylated regions correlated with inflammatory/immune pathways. For example, in adipocytes from high-fat diet fed mice they found hypermethylation sites within the promoter of Pck1 gene encoding Phosphoenolpyruvate Carboxykinase, which catalyses the rate-limiting step in glyceroneogenesis in adipose tissue, a key pathway for fatty acids storage as triacylglycerols. Moreover, this study reported for the first time DMRs in Fasn gene encoding fatty acid synthase; these DRMs correlated with differences in terms of glucose tolerance test. Accordingly, there are several evidences indicating that de novo lipogenesis in adipose tissue is impaired during metabolic dysfunction and that restoring this pathway selectively in WAT could be a strategy to improve obesity-dependent insulin resistance (Cao et al. 2008; Roberts et al. 2009; Huo et al. 2012) . Of note, these authors also 
precursors of these pathways. It is well known that deficiency of these nutrients may lead to hepatic fatty acid accumulation (Zivkovic et al. 2009; Kajikawa et al. 2011) . At this regard, it has been shown that supplementation with dietary methyl donors in high fat sucrose (HFS) fed Wistar rats reduced hepatic fat accumulation with decreased level of global DNA methylation in supplemented control fed animals (Cordero et al. 2013) . In particular, the authors showed changes in DNA methylation profile at CpG sites of Sterol Regulatory Element Biding Protein 2 (Srebf2), 1-acylglycerol-3-phosphate O-acyltransferase 3 (Agpat3), and Estrogen Receptor 1 (Esr1) promoters.
Conversely, another study demonstrated that methionine restricted diets protects adult mice from age-related DNA hypomethylation in the liver. These investigators found increased hepatic global DNA methylation and reduced levels of S-adenosylhomocysteine (SAH), an important intermediate for DNA methylation reactions (Mattocks et al. 2016 ). These studies highlighted that diet may influence hepatic lipid metabolism by epigenetic control of gene expression. However, the opposite outcomes obtained in these studies highlights the need of more conclusive investigations to assess a possible link between methionine restriction and epigenetic regulation of lipid metabolism.
Histone modifications
Histone methylation is another epigenetic modification strictly linked with metabolism. It has been assessed that high fat diet ( In 2009, two studies highlighted that the genetic ablation of H3K9-specific demethylase Jmjd1a, Jumonji domain containing 1A, induced metabolic impairment and obesity. Tateishi et al. (Tateishi et al. 2009 ) showed that mice lacking Jmjd1a developed obesity and hyperlipidemia in the adulthood. This was due to dysregulation of Ppara and Ucp1, two direct targets of Jmjd1a, in brown adipose tissue as a consequence of increased H3K9me2 levels at enhancers of these two genes. Moreover, they showed that Jmjd1a expression is induced upon β-adrenergic stimulation in brown adipose tissue (BAT). In addition, in the study of Inagaki et al. (Inagaki et al. 2009 ) the obese phenotype in Jmjd1a-/-mice correlated with reduced expression of several genes including those encoding the inhibitor of fat storage ApoC1, the insulin dependent glucose transporter Glut4, the anti-adipogenic transcription factor CoupTFII and Adamts9, which encodes a metalloprotease associated with type 2 diabetes. Recently, the same group disentangled the physiological role of Jmjd1a in the acute response to environmental factors, i.e. cold exposure, in brown adipose tissue.
The authors demonstrated that Jmjd1a serves as a cAMP epigenetic sensor that induces a long-range looping of enhancer regions to transcription start site (TSS) to initiate transcription of thermogenic genes in BAT (Abe et al. 2015) . In particular, they showed that Jmjd1a is phosphorylated at Ser265
by PKA in response to β-adrenergic activation. As a consequence, Jmjd1a forms a complex with Swi/SNF proteins and PPARγ upon enhancers of thermogenic genes Adrb1 and Ucp1, which brings M A N U S C R I P T
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enhancers in proximity of TSS of these genes thus stabilizing the recruitment of RNA pol II and inducing their transcription. This mechanism was independent from the demethylase activity of the protein.
In a recent paper Mentch and colleagues (Mentch et al. 2015) showed that histone methylation dynamics senses rapid alterations in methionine metabolism. They found global alterations of histone methylation after methionine restriction in vitro and in vivo, with H3K4me3 levels being reduced within 2-4 hours after methionine deprivation. Since H3K4me3 marks active promoters, they evaluated also changes in gene transcription: one of the most down-regulated pathways was indeed a network of enzymes involved in one-carbon metabolism that showed reduced both H3K4me3 levels and mRNA levels. This suggested the inception of a feedback regulatory pathway to cope methionine restriction and maintain physiological homeostasis. Summarizing, this study demonstrated that cells could sense nutritional status and adapt to methionine restriction by modulating histone methylation levels and gene expression. A number of studies extensively demonstrated the tight link between histone deacetylases (HDACs) and metabolism. Several investigations dissected the role of specific histone deacetylases in the regulation of metabolism in specific tissues by using knock out murine models or chemical inhibitors (Chang et al. 2006; Potthoff et al. 2007; Knutson et al. 2008; Gao et al. 2009; Sun et al. 
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2011; Galmozzi et al. 2013) . At this regard, Knutson et al. (Knutson et al. 2008 ) demonstrated that hepatic Hdac3 deletion disrupted normal regulatory networks and altered completely metabolic homeostasis causing hepatomegaly, hepatosteatosis and impairments of glucose and lipid metabolism. These alterations were due to activation of PPARγ regulatory network within the liver.
Indeed, HDACs regulatory activity depends upon the co-recruitment of multi-protein complexes.
For example, HDAC3 deacetylase activity requires interaction with corepressors Silencing
Mediator for Retinoid and Thyroid Receptors (SMRT) and Nuclear Receptor Corepressor (Cd36) loci. The association of HDAC3 with hepatic genome is also regulated by the nuclear receptor Rev-erbα in a circadian fashion (Feng et al. 2011 ). During dark phase, when murine metabolism is active and in the feeding phase, low concentrations of Rev-erbα lead to dissociation of HDAC3 from the genome. Thus, acetylation levels at H3K9 are up-regulated during dark phase leading to increased expression in genes involved in hepatic de novo lipogenesis and this is reverted during light phase. Disruptions of this circadian mechanism lead to alteration in the epigenome that may contribute to the development of fatty liver.
HDAC3 plays an important role in the regulation of lipid metabolism also in the heart. At this regard, Montgomery and coworkers (Montgomery et al. 2008) reported that cardiac specific ablation of Hdac3 upregulated expression of genes associated with an intense oxidative program (e.g., genes involved in fatty acid uptake, fatty acid oxidation, and electron transport chain/oxidative phosphorylation). These effects are related to hyperactivation of the nuclear receptor PPARα, which, together with HDAC3, forms a repressive complex on key target genes (Ucp2, Ucp3, Pdk4, Fatp) . However, Sun et al. showed that Hdac3 cardiac-ablated mice exposed to high fat diet developed hyperthrophic cardiomyopathy, heart failure and lethality. In this experimental setting Hdac3 ablation was, in fact, accompanied by downregulation of genes involved in lipid catabolism and fatty acid oxidation, thus Hdac3 heart-specific knock out mice
were not able to metabolize efficiently the dietary lipids and died from heart failure. This study demonstrated that HDAC3 transcriptionally regulates lipid catabolism in the heart and that loss of HDAC3 reduces the ability to respond to lipid overload, highlighting that high fat feeding reverts metabolic remodeling observed upon Hdac3 ablation in mice fed low fat diet (reported in Montgomery et al. 2008) .
Acetyl-CoA is as an important substrate of histone acetyltransferase (HAT) enzymes and represents the source of acetyl groups for histone acetylation (Wellen et al. 2009 ), indicating a link between metabolism and epigenetics. The nuclear ATP-citrate lyase (ACLY), the enzyme that converts citrate into acetyl-CoA and oxaloacetate, provides acetyl-CoA required to sustain histone acetylation. In the same study, these authors also demonstrated that reduced glucose concentration affected ACLY-dependent histone acetylation, thus suggesting that glucose metabolism is the major source of acetyl groups for acetylating chromatin.
It would be interesting to verify whether, under particular metabolic conditions, lipid catabolism (i.e. fatty acid β-oxidation) could also be a source of acyl-CoA for chromatin acetylation.
Non-coding RNA
The discovery that non-coding RNAs (ncRNAs) account for almost two thirds of all transcripts raised interest in this fascinating mechanism of gene regulation. Some evidences support the possibility that long non-coding RNAs (lncRNAs) play a role in the regulation of lipid metabolism.
At this regard, a liver-specific lncRNAs, named long non-coding liver-specific triglyceride regulator (lncSTR) , whose expression is influenced by the nutritional status, has been identified. Knock down of lncSTR in vivo increased triglycerides clearance also in a setting M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
of hyperlipidaemia, the ApoE -/-mouse. The authors have also found that lncSTR is part of a molecular complex with TAR DNA binding protein 43 (TDP-43) that regulates the expression of Cytochrome P450 8b1 (Cyp8b1), a key enzyme in the bile acid synthesis pathway. This mechanism determines a specific bile acid pool that activates Farnesoid -X-receptor (FXR), which, in turn, induces apoC2 expression.
Recently, Yang and colleagues used an integrated approach to identify 359 putative long non coding RNAs (lncRNA) that function as metabolic regulators in liver, adipose tissue and skeletal muscle . They found Gm16551, a liver-specific lncRNA strongly regulated by the master transcription factor of lipogenesis, SREBF1c. Liver-specific Gm16551 knock down mice Recently, it has been demonstrated that miRNAs could act in a concerted fashion to regulate lipid metabolism (Jeon et al. 2013) . For example, mir-182 and miR-96 are expressed from the same polycistronic locus in response to transcription factor SREBP-2. By acting as a "miRNA operon"
this two miRNAs reduce the expression of F-box and WD-40 domain protein 7 (Fbxw7), and Insig-2, insulin induced gene 2, respectively, two genes that negatively regulate SREBP2 by reducing its nuclear localization. (Dick et al. 2014 ). This result is in line with other reports demonstrating that HIF system is involved in metabolic regulation and energy expenditure (Jiang et al. 2011) . Recently, an association between adipose tissue DNA methylation and mRNA expression in human adipose tissue and three risk factors for metabolic diseases, i.e. age, BMI and HbA1c (a measure of long-term glycaemia) has also been shown (Rönn et al. 2015) . The authors found significant correlations between age and methylation in CpG sites in genes involved in lipid metabolism, such as fatty acid elongase 2 (ELOVL2) in both blood and adipose cells. Of note, this evidence highlights that blood-based epigenetic biomarkers mirror epigenetic signatures in metabolic tissues, suggesting that epigenetic marks may become interesting biomarkers of metabolic disorders in obesity, T2D and related diseases. The possibility of a rapid identification of these epigenetic biomarkers could allow a prompt and appropriate therapeutic intervention. Another important gene whose DNA methylation was increased in human adipose tissue and blood cells with increased age was Kruppel-like factor 14 (KFL14). GWAS studies identified an association between SNPs near KFL14 and type 2 diabetes and HDL cholesterol levels (Wang et al. 2014) , further confirming the strict link between genetics and epigenetics in metabolic regulation, and providing new insights in the pathophysiology of obesity and related disorders. At this regard, Ahrens and co-workers (Ahrens et al. 2013) reported that non-alcoholic fatty liver disease (NAFLD), a pathologic condition associated to obesity, correlates with a peculiar hepatic methylation signature. The authors found NAFLDspecific expression and methylation differences for genes regulating metabolism. Among these genes the authors identified ATP citrate lyase (ACLY). ACLY, catalysing the conversion of citrate into acetyl-CoA, is the first enzyme of fatty acid biosynthesis (Linn and Srere 1979) Non-alcoholic steatohepatitis determined decreased DNA methylation of ACLY gene, paralleled by higher ACLY mRNA expression, indicating activation of a lipogenic pathway in NAFLD patients. Moreover, the M A N U S C R I P T
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authors compared liver biopsies before and after bariatric surgery and found that NAFLDassociated methylation changes are partially reversible, demonstrating the possibility to remodel human epigenome through a therapeutic intervention. However, the possibility to selectively manipulate DNA methylation at specific epigenomic regions is a really challenging task, rather we envision the value of identifying differences in DNA methylation as useful biomarkers for the efficacy of pharmacological approaches in metabolic disorders.
Another organ whose functionality is impaired in obesity is skeletal muscle. In skeletal muscle of obese patients the rate of fatty acid β-oxidation (FAO) is reduced (Kim et al. 2000) , thus contributing to ectopic lipid accumulation. Maples et al (Maples et al. 2015) recently reported that blunted expression of carnitine palmitoyltransferase-1B (CPT1B) in primary human skeletal muscle cultures from obese women was accompanied by changes in CpG methylation. CPT1B mediates the transfer of long-chain fatty acids from the cytosol to the mitochondrial matrix and is a rate-limiting step in FAO. The authors found that, in response to a lipid overload, cell cultures from lean subjects showed increased expression of CPT1B, as result of reduced cytosine methylation in CPT1B
promoter. In cells from obese patients this epigenetic remodelling is blunted, preventing the binding of key transcriptional activators such as peroxisome proliferator-activated receptor-δ (PPARδ) and hepatocyte nuclear factor 4α (HNF4α) to CPT1B promoter.
Recently, an epigenome-wide association showed a correlation between obesity and deep changes in DNA methylation (Wahl et al. 2017) . The authors demonstrated these modifications occur as result of adiposity and they are not to be considered as the cause of obesity and related metabolic impairment. Interestingly from this study emerged the existence of sentinel methylation markers, associated to obesity, that determine gene expression signatures at specific loci, mostly corresponding to genes involved in lipid and lipoprotein metabolism, substrate transport and inflammatory pathways. The authors also demonstrated that alterations of DNA methylation profile on these loci could be predictive of the M A N U S C R I P T
future development of obesity-related disease, such as type 2 diabetes, paving the way for new prevention strategy for the onset of this pathology.
All these experimental evidences demonstrate that DNA methylation profile strongly influences lipid metabolic pathways in several organs participating in energy homeostasis, and link indissolubly metabolic disorders and epigenome remodelling.
It is important to notice that prenatal environment could influence DNA methylation. A study on
Gambian pregnant women demonstrate that seasonal alterations in methyl-donor nutrient intake at the time of conception influences several plasma biomarkers predicting differential DNA methylation in lymphocytes and hair follicles obtained from infants postnatally (Dominguez-salas et al. 2014) . Other authors investigated genome-wide DNA methylation on whole blood of adult offspring whose mothers were exposed to famine during the Dutch Hunger Winter (Heijmans et al. 2008 ). This study highlighted that differential DNA methylation occurred only in subjects that were exposed to famine during early gestation (periconceptional exposure). Among the DNA regions differentially methylated, the authors identified genomic portion of INSR and CPT1A that were shown to have enhancer activity in vitro: differential methylation in these sites has been associated with birth weight and serum LDL-cholesterol. These results prove the link between the timing of nutritional challenges and epigenetic remodelling, which can alter metabolism.
Histone modifications
In analogy to evidences coming from studies in rodents, a link between metabolic disorders and histone modifications has also been demonstrated in humans. It has in fact been shown that global histone H3 methylation status changes in response to overweight: in particular the authors reported decreased lysine 4 dimethylation of histone H3 (H3K4me2) in adipocytes from diabetic and non diabetic obese subjects (Jufvas et al. 2013) . On the other hand, they found that trimethylation of H3K4 (H3K4me3) was 40% higher in adipocytes from overweight diabetic subjects compared with normal-weight and overweight non-diabetic subjects. These results highlight that obesity and Recent evidences demonstrated that histone modifications are important determinants also of hepatic metabolic signature: it has been shown that lysine-specific demethylase 2 (LSD2) regulates lipid metabolism in human hepatocytes (Nagaoka et al. 2015) . The authors reported that LSD2, demethylating H3K4, is able to repress genes involved in lipid influx and metabolism, and that cJun mediates recruitment of LSD2 on these genes. Interestingly they demonstrated that knock down of LSD2 increased intracellular levels of many lipid metabolites, thus determining higher susceptibility to cellular damage induced by exposure to free fatty acids.
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microRNAs
In recent years we have witnessed a growing interest in microRNAs in the pathophysiology of nonalcoholic steatohepatitis (NASH). Cheung and coworkers (Cheung et al. 2008) , by comparing the expression of 474 human microRNAs in subjects with NASH versus controls (without lipid deposition in the liver), found that the expression of miR-122, the most abundant miRNA in the liver, was reduced in NASH. As a consequence of miR122 underexpression, the authors reported (Soronen et al. 2016) . PPARα/RXRα activation pathway was identified among the target pathways of these miRNAs. Indeed PPARα activates β-oxidation and it is known that its expression is reduced in NAFLD (Tyagi et al. 2011) . Suppression of the PPARα/RXRα pathway by miRNAs reduces the rate of fatty acid oxidation, thus favouring lipogenesis and progression of liver disease.
Conclusions
The evidences from human and animal studies here reviewed ( Figure 3 ) demonstrated that nutritional and lifestyle factors (both pre-and postnatal) impact epigenome remodelling, and finely regulate lipid metabolism. The study of epigenetic modifications related to metabolic pathologies in rodents is a valuable strategy in order to identify new targets for the treatment of human diseases.
At this regard a similar DNA methylation pattern in murine and human obesity has been shown: to 
